Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea flag South Korea · Delayed Price · Currency is KRW
990.00
-27.00 (-2.65%)
Mar 25, 2026, 7:48 AM KST

Enzychem Lifesciences Revenue

In the year 2025, Enzychem Lifesciences had annual revenue of 67.75B KRW, down -12.44%. Enzychem Lifesciences had revenue of 14.10B in the quarter ending December 31, 2025, a decrease of -23.87%.

Revenue
67.75B
Revenue Growth
-12.44%
P/S Ratio
1.13
Revenue / Employee
521.16M
Employees
130
Market Cap
76.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202567.75B-9.63B-12.44%
Dec 31, 202477.38B1.34B1.76%
Dec 31, 202376.04B49.40B185.46%
Dec 31, 202226.64B3.66B15.94%
Dec 31, 202122.98B-2.84B-11.01%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jeil Pharma Holdings657.61B
Ildong Holdings590.89B
HANDOK535.14B
Dongwha Pharm.Co.,Ltd496.39B
MYUNGMOON Pharm co.,Ltd193.64B
Kukje Pharma175.50B
CKD Bio159.93B
Yuyu Pharma139.51B
Revenue Rankings